News 
Variational AI Announces Oversubscribed $5.5 Million Financing to Launch Foundation Model for Small Molecule Drug Discovery
VANCOUVER, BC, February 20, 2025 — Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, today announced the completion of its oversubscribed $US5.5 million Seed extension round. Enki™ empowers biopharmaceutical chemistry teams to efficiently discover and optimize novel hits and leads, accelerating early-stage drug discovery. The round attracted strong investor interest, exceeding the company’s initial funding target, reflecting confidence in Enki’s potential. Nimbus Synergies led the round, with participation from Merck Global Health Innovation Fund, Quimby Investments, Threshold Impact, and Defined Capital.
Nimbus Synergies Unveils New Era of The GENERATOR Startup Hub
Vancouver, BC - May 15, 2024 - Nimbus Synergies is excited to announce the re-opening of The GENERATOR, a rent-free startup hub for health technology companies, at its new location on the corner of West Broadway and Oak Street in Vancouver. The reimagined space boasts a mix of new and returning startup ventures, united by their dedication to healthcare innovation.
Nimbus Synergies Partners with Spring Activator to Drive Health Impact Investments
Nimbus Synergies is delighted to partner with Spring Activator to introduce the Health Impact Investor Challenge, a program poised to drive positive change within the healthcare sector. Organized and led by Spring Activator, this initiative empowers both seasoned and aspiring investors with essential knowledge and tools for meaningful investments in health-focused, purpose-driven enterprises.
Nimbus Synergies Catalyzes BC-Based Health Innovation with New GENERATOR Startup Hub
Nimbus Synergies, a leading Canadian early-stage health technology investor and mentor to Canada's most promising health tech entrepreneurs, is excited to announce the GENERATOR’s relocation to new office space situated on the corner of West Broadway and Oak. This physical move marks the most significant strategic change in the GENERATOR’s 12-year history as it shifts focus to nurturing health tech startups exclusively.
Nimbus Synergies Leads Investment in MetaOptima to Accelerate FDA Approval and US Market Adoption of its AI-Powered Skin Diagnostics Platform
Nimbus Synergies, a leading Canadian early-stage health technology investor, has led a $2.6 million investment in MetaOptima Technology, a digital health company that is revolutionizing the dermatology and skin care industry with affordable, effective, and intelligent AI-driven solutions. Existing investors, including Skip Capital and AirTree Ventures, also contributed to the funding round.
VitaminLab Accelerates Growth of Personalized Supplementation through Series A Financing
Vitamin-One Formulas Ltd (dba VitaminLab), a leader in truly personalized supplements designed to meet individual health needs, today announced that it has closed a Series A investment round co-led by Nimbus Synergies and DSM Venturing. The proceeds of the financing will be used to expand VitaminLab’s facilities and state-of-the-art automation lines as well as scale its go-to-market activities across North America.
Spring Activator, Nimbus Synergies, and Discovery Foundation team up to launch program to strengthen impact focused health innovation in BC
Nimbus Synergies, an investor, partner, and mentor to early-stage health tech startups based in Canada, is proud to announce its partnership with Spring Activator, the Discovery Foundation, and Innovate BC to launch a program that strengthens impact focused health innovation ecosystem in BC.
Nimbus Synergies appoints Nancy Harrison to its Board of Directors to strengthen its position in Canadian Health Tech
Nimbus Synergies, investor, partner, and mentor to Canada’s most promising health technology companies, is pleased to announce the appointment of Nancy Harrison to the Board of Directors. Nancy is a nationally recognized life sciences entrepreneur and investor with almost 30 years of experience as an innovator and leader in the sector.
Nimbus Synergies Co-Leads $2.26 Million Investment in Arbutus Medical to Accelerate Market Adoption of Skeletal Traction Innovation
Nimbus Synergies is pleased to announce the completion of a $2.26 million follow-on investment in portfolio company Arbutus Medical. This investment was led by Nimbus Synergies and Genome BC’s Industry Innovation (I²) Fund to support the commercialization of Arbutus Medical’s TrakPak® – a complete single-use procedure kit that contains everything a surgeon needs for skeletal traction.
Nimbus Synergies Appoints New Board Member Michael Ball to Enhance Leadership in Canadian Health Tech
Nimbus Synergies, investor, partner, and mentor to Canada’s most promising health technology companies, is pleased to announce the appointment of Michael Ball to the Board of Directors of Discovery Parks and Nimbus Synergies. Michael was also appointed to Nimbus’ Health Tech Investment Committee. Michael Ball is an industry veteran with over 30 years of global business experience leading and scaling innovative healthcare start-ups to exit through C-suite, board, and advisory roles.
Nimbus Synergies has a new Office Manager!
We recently welcomed our new Office Manager, Arushi Gupta, completing the team at Nimbus Synergies. With a background in Marketing & Project Management, Ari has transitioned to the role of Office Manager to manage administrative responsibilities, increase engagement within the Nimbus Portfolio and support the developments taking place within the Discovery Group.
Jason Robertson named Partner to strengthen Nimbus Synergies’ leadership in Canadian Health Tech
Nimbus Synergies, investor, partner, and mentor to Canada’s leading health technology companies, is pleased to announce the appointment of Jason Robertson as Partner. Jason is a nationally recognized venture capital investor with almost 20 years of experience as a healthcare leader and innovator.
Nimbus Synergies expands Investment team with its new Associate, Vivian Wang
The Discovery Group is expanding its team by bringing on Vivian Wang as Investment Associate at Nimbus Synergies. Vivian will be joining Nimbus Synergies in a full-time capacity as she completes her MBA from UBC Sauder School of Business. "We would like to give a warm welcome to Vivian Wang as our new Investment Associate at Nimbus Synergies.
Nimbus Synergies appoints new Director of Finance
The Discovery Group has appointed Mathew Merritt as Director of Finance, Nimbus Synergies. Mathew will be taking over for Alfred Sequeira, who is retiring in early 2023. Mathew joins us after spending over two years at Vancouver based start-up, Bear’s Blooms, as their CFO.
Laura Cassin, promoted to Investment Associate
We are pleased to announce the promotion of Laura Cassin, to Investment Associate. 2022 marks the 11th year that Laura has been part of the Discovery Parks team and over that time, her role has evolved substantially to reflect our changing activities.
Nimbus Synergies Leads $20 Million Strategic Investment in Clarius Mobile Health to Accelerate Growth
Nimbus Synergies, investor, partner, and mentor to Canada’s leading health technology companies, is pleased to announce the completion of a $20 million strategic investment in Clarius Mobile Health. This new investment was led by Nimbus Synergies and Export Development Canada to enable Clarius to expand its commercial scale and capitalize on the momentum created by the introduction of the company’s third-generation product line earlier this year.
Nimbus Synergies Portfolio Company ALAViDA Acquired by LifeSpeak to Deliver Substance Use Support to Millions of People Globally
Nimbus Synergies, investor, partner, and mentor to Canada’s leading health technology companies, is pleased to announce that ALAViDA Health Ltd. (“ALAViDA”), one of its earliest portfolio companies, was acquired by LifeSpeak Inc. (TSX: LSPK) in October 2021.
Nimbus Synergies Portfolio Company Blue Mesa Health Acquired by Virgin Pulse
Vancouver, British Columbia, January 15, 2020 – Nimbus Synergies, investor, partner, and mentor to British Columbia’s leading health technology companies, is pleased to announce that Blue Mesa Health, one of its portfolio companies, has been acquired by Virgin Pulse, the leading global provider of enterprise SaaS solutions that simplify health and wellbeing.